Skip to content

Activate program

Global pharmaceutical companies are working with active pharmaceutical ingredient (API) supply chains to enable environmental impact reduction of the healthcare sector through the Activate program.

Activate supports the decarbonization of a key segment of the pharmaceutical value chain through measurement, provision of practical tools, expert advice, and access to green funding.


The Challenge

Active Pharmaceutical Ingredients (APIs), a key constituent in medicines and vaccines that produce the intended health effects, can be resource-intensive to manufacture due to material use, energy-intensive processes and waste recovery.

Selection of different coloured tablets and capsules sat on a blue surface and photographed from above

The Opportunity

With high levels of interconnectivity across the industry’s supply chains, there is a substantial opportunity to drive positive impact through collaboration across the sector.

The Solution

Activate goes beyond data collection and works closely with API suppliers to strengthen relationships, align with science-based decarbonization targets, drive more sustainable procurement, and identify opportunities for operational and resource efficiency.

M2030 independently facilitate the program, maintaining confidentiality, convening pharmaceutical companies, and leading on supplier engagement by using our innovative carbon reduction software, climate action managers and its extensive network of expert partners.

Participating pharmaceutical companies gain access to projections of the decarbonization pathway for API suppliers. This increased visibility can aid climate risk assessment and empower supply chain owners to support suppliers in meeting their climate targets.

Pipette dropping liquid into a rack of test tubes bathed in red and blue light

Rolling out now

Rolling out across more than 20 countries, Activate's immediate focus includes onboarding API suppliers, capturing footprint data, establishing a reference point baseline, and tackling the most prominent areas of environmental impact.

The second phase of Activate is intended to launch in April 2024 and will see M2030 bring participants together to explore solutions to more complex challenges.

These will include support for building product carbon footprints (PCFs) at scale; deploying new tools and technologies collaboratively; and promoting access to green finance for decarbonization projects via independent financial partners.

Discover more about Activate and find out how to participate